Real-time enrollment status for this rheumatoid arthritis (ra) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:51 AM UTC
| NCT Number | NCT07258849 |
| Recruiting Status | Recruiting |
| Condition | Rheumatoid Arthritis (RA) |
| Phase | PHASE1 |
| Target Enrollment | 141 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | June 23, 2026 (Jun 23, 2026) |
As of August 28, 2026: Clinical trial NCT07258849 is currently recruiting participants. This phase1 study for rheumatoid arthritis (ra) is actively seeking new participants at 9 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07258849 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07258849 was last updated Jun 23, 2026 (June 23, 2026). HelloStudys verifies this status automatically.